Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection.

European journal of internal medicine - 1 Jan 2024

Angeli Fabio, Zappa Martina, Verdecchia Paolo

Abstract excerpt

Several reports documented a specific effect of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on blood pressure (BP), during and after the acute phase of infection. Clinical studies demonstrated that coronavirus disease 2019 (COVID-19) is associated with an increased risk of a persistent increase in BP requiring a new or intensified anti-hypertensive treatment during hospitalization. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to ACE2 gene
Share to Hypertension

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Peptidyl-Dipeptidase A

Share to SARS-CoV-2

Source

Identifiers

PMID: 37852842
DOI: 10.1016/j.ejim.2023.10.016

Genes

ACE2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection.PMID 37852842Read ↗

Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational studySemantic proximity Read ↗

Clinical Features of Hypertensive Patients With Covid-19 Compared With a Normotensive GroupSemantic proximity Read ↗

ARB/ACEI use and severe COVID-19: a nationwide case-control studySemantic proximity Read ↗

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19Semantic proximity Read ↗

Influenza Viral Infection is a High-Risk Factor for Developing Coronavirus Disease 2019 (COVID-19)Semantic proximity Read ↗

SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.Semantic proximity Read ↗

Effects of Hypertension on the Outcomes of COVID-19: A Multicenter Retrospective Cohort StudySemantic proximity Read ↗

Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidneySemantic proximity Read ↗

The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study).Semantic proximity Read ↗

Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19Semantic proximity Read ↗

Role of renin-angiotensin-aldosterone system in the interaction with coronavirus SARS-CoV-2 and in the development of strategies for prevention and treatment of new coronavirus infection (COVID-19)Semantic proximity Read ↗

Antihypertensive medication uses and serum ACE2 levelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.